🔬 Science
May 2, 2026
FDA approves once-daily Idvynso tablet for treating HIV
Source ↗
👁 1
💬 0
The U.S. Food and Drug Administration has approved Merck's Idvynso (doravirine/islatravir), a new, once-daily, two-drug single tablet for the treatment of HIV-1 infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA
Comments (0)